Oxycodone/paracetamol controlled release

Drug Profile

Oxycodone/paracetamol controlled release

Alternative Names: DDS-06B; DDS-08B; oxycodone/acetaminophen - Labopharm; Oxycodone/paracetamol - INTELLITAB™

Latest Information Update: 31 Mar 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Labopharm
  • Developer Endo International
  • Class Acetanilides; Antipyretics; Antirheumatics; Morphine derivatives; Non-opioid analgesics; Opioid analgesics
  • Mechanism of Action Opioid delta receptor agonists; Opioid kappa receptor agonists; Opioid mu receptor agonists; Prostaglandin receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Pain

Most Recent Events

  • 28 Feb 2014 Endo Health Solutions and Paladin Labs combine to form Endo International
  • 07 Oct 2011 Labopharm has been acquired by Paladin Labs
  • 07 May 2011 Oxycodone/paracetamol is available for licensing (http://www.labopharm.com)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top